Posted by Michael Wonder on 16 Aug 2022
Sales from controversial drug discount program rose to $44 billion last year
15 August 2022 - Prescription medicines purchased in the US under a controversial government discount program amounted to $44 billion in 2021, a nearly 16% increase from the previous year, according to the Health Resources & Service Administration, which oversees the program.
The data mark a steady rise in sales under the 340B Drug Discount Program, which requires drugmakers to offer discounts that are typically estimated at 25% to 50% - but could be higher - on all outpatient drugs to hospitals and clinics that primarily serve lower income patients.
